Breaking News
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
Otsuka Completes $1.23B Buyout of Transcend Therapeutics
PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical ...
North Carolina Lawmakers Unite Behind Psychedelic Research Bill for Veterans
RALEIGH – NC Lawmakers from both parties held a press ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Cannabis B2B Gets a Credit Layer: FundCanna Plugs BNPL Into Apex Trading
SAN DIEGO – FundCanna, the largest dedicated provider of working capital to operators in the regulated Cannabis industry, announced a strategic partnership with Apex Trading, one of the fastest-growing B2B marketplaces in Cannabis. The deal ...
Aurora Cannabis Reports FY and Fiscal Q4 2026 Financial Results
EDMONTON – Aurora Cannabis Inc. reported its financial and operational results for the fourth quarter and fiscal year ending March 31, 2026. For the full fiscal year, net revenue rose 11% to CA$321 million, exceeding ...
Optimi Ships Psilocybin to the UK for Phase 2 Trial
VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...
